Pulse Biosciences, Inc. (6L8)

Overview

Pulse Biosciences, Inc. is a pioneering bioelectric medicine company, previously known as Electroblate, Inc. until its name change in December 2015. Founded in 2014, the company has quickly positioned itself at the forefront of medical technology innovation with its headquarters in Hayward, California. The company's core mission revolves around developing novel therapeutic devices that leverage its unique Nano-Pulse Stimulation (NPS) technology. This technology represents a significant advancement in treating a broad spectrum of medical conditions by delivering nano-second pulses of electrical energy directed at targeted cells. Unlike traditional methods, this approach ensures the non-thermal destruction of cells while preserving adjacent non-cellular tissues, marking a new era in precision medicine.

Products and Services

The cornerstone of Pulse Biosciences’ offering is the CellFX System. This platform embodies the practical application of Nano-Pulse Stimulation technology in clinical settings. Details of the product include:

• CellFX System: A tunable, software-enabled, console-based platform designed for precision. It harnesses the power of nano-second duration pulses of electrical energy. The system's unique capability to non-thermally clear targeted cells without damaging adjacent non-cellular tissue addresses a vast array of medical conditions. Its versatility and efficacy position it as a revolutionary tool in the field of bioelectric medicine.